Basic Information
ID: ALA4009443
Type: ADME
Description: Drug level in human HCT116 cells assessed as ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-pyrrolo[2,3-d]pyrimidine at 10 umol/L after 3 hrs by UPLC-MS/MS analysis
Format: BAO_0000219
Organism: Homo sapiens
Target: Adenosine kinase(ALA3589)
Document: ALA4007430
Drug level in human HCT116 cells assessed as ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-pyrrolo[2,3-d]pyrimidine at 10 umol/L after 3 hrs by UPLC-MS/MS analysis: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4009443
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 455.39 | 1.10 | 1.10 |